Repcros Pharmaceutical Private Limited
About Repcros Pharmaceutical Private Limited
Data last updated:
Repcros Pharmaceutical Private Limited is a private limited company based in New, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52590DL2015PTC282902. Its GSTIN is 07AAHCR4493A1ZF (Delhi).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sandeep Kumar and Kuldeep Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No 205 Second Floor Plot No 1 Pocket D, Lsc Capital Tower Inder Enclave Richmond Global Public School, New, Delhi, India – 110087.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.29 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹2.68 Lakh (net margin 2.1%) and EBITDA of ₹8.85 Lakh (EBITDA margin 6.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No 205 Second Floor Plot No 1 Pocket D, Lsc Capital Tower Inder Enclave Richmond Global Public School, New, Delhi, India – 110087
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Repcros Pharmaceutical Private Limited
The main business activity of Repcros Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Repcros Pharmaceutical Private Limited
Repcros Pharmaceutical Private Limited is audited by Chandni Malhotra for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Chandni Malhotra | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Repcros Pharmaceutical Private Limited
Repcros Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar | Director | 17 Jul 2015 | 11 Years 2 Months | Current |
| Kuldeep Singh Also directs: Alkene Pharmaceuticals Private Limited | Director | 17 Jul 2015 | 11 Years 2 Months | Current |
Financials of Repcros Pharmaceutical Private Limited FY 2025 filings available
Repcros Pharmaceutical Private Limited reported revenue of ₹1.29 Cr (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Repcros Pharmaceutical Private Limited
Revenue rose 2% in the latest year. EBITDA rose 242% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Repcros Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.68 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Repcros Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Repcros Pharmaceutical are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Repcros Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Repcros Pharmaceutical Private Limited
Repcros Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Repcros Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Repcros Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Repcros Pharmaceutical Private Limited
Repcros Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCR4493A1ZF | Delhi | Active | 26 Feb 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Repcros Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Repcros Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Repcros Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Repcros Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Repcros Pharmaceutical Private Limited
Frequently Asked Questions about Repcros Pharmaceutical Private Limited
Repcros Pharmaceutical is an active private limited company based in New, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 July 2015 (11+ years old) and is registered under CIN U52590DL2015PTC282902.
Repcros Pharmaceutical reported revenue of ₹1.29 Cr for FY 2024 (up 2% YoY).
Repcros Pharmaceutical has 2 current directors:
- Sandeep Kumar - Director
- Kuldeep Singh - Director
Repcros Pharmaceutical reported a net profit of ₹2.68 Lakh (net margin 2.1%) and EBITDA of ₹8.85 Lakh (EBITDA margin 6.9%) for FY 2024, as per its filed financial statements.
The GSTIN of Repcros Pharmaceutical is 07AAHCR4493A1ZF, registered in Delhi.
The CIN (Corporate Identification Number) of Repcros Pharmaceutical is U52590DL2015PTC282902. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Repcros Pharmaceutical was incorporated on 17 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The registered office of Repcros Pharmaceutical is at Office No 205 Second Floor Plot No 1 Pocket D, Lsc Capital Tower Inder Enclave Richmond Global Public School, New, Delhi, India – 110087.
Repcros Pharmaceutical has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh.